Compare Humana Inc (HUM) vs Prudential PLC (PUK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Prudential PLC — how do they compare? Humana Inc trades at $406.99 (market cap $47.81B), while Prudential PLC trades at $28.9 (market cap $34.25B). The key difference: Humana Inc is the larger of the two by market cap, and Prudential PLC pays the higher dividend (1.88%). Which is the better fit depends on your goals.
| HUM | PUK | |
|---|---|---|
Market Cap | $47.81B | $34.25B |
Sector | Health | Financials |
52-Week High | $409.42 | $33.61 |
52-Week Low | $163.67 | $24.74 |
Enterprise Value | $56.85B | $35.69B |
Dividend Yield | 0.89% | 1.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Prudential PLC (PUK) trades at $28.275, showing minimal daily movement with a slight 0.05% decline. The stock presents strong fundamentals with a P/E of 9.21 and robust profitability metrics including 21.15% ROE and 14.52% net income margin. Recent earnings have exceeded expectations, with Q4 2025 EPS beating estimates by 46%. Technical indicators show a bullish overall signal despite mixed moving average signals, while analyst consensus leans positive with 50% buy ratings.
PUK offers attractive value with reasonable valuation multiples and consistent earnings growth, though faces headwinds from regulatory challenges in key markets like Japan and China. The company's strategic expansion in India through the Bharti Life acquisition and strong cash flow generation support long-term growth prospects, but investors should monitor regulatory developments in Asian markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Prudential PLC
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →
